Soheir Beshara
Overview
Explore the profile of Soheir Beshara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paucar M, Wincent J, Rubin C, Peikert K, Kyhle J, Hertegard S, et al.
Front Neurosci
. 2024 Oct;
18:1409366.
PMID: 39416949
Background And Objectives: The diseases historically known as neuroacanthocytosis (NA) conditions include disease (formerly chorea-acanthocytosis) and disease (formerly McLeod syndrome). Here we report a patient with a hyperkinetic syndrome associated...
2.
Pistis K, Westerberg P, Qureshi A, Beshara S, Sterner G, Barany P, et al.
BMC Nephrol
. 2023 Jan;
24(1):20.
PMID: 36698076
Background: Hepcidin is considered to play a central role in the pathophysiology of renal anemia. Recent studies in healthy individuals have demonstrated a suppressive effect of vitamin D (VD) on...
3.
Marmur J, Beshara S, Eggertsen G, Onelov L, Albiin N, Danielsson O, et al.
BMC Gastroenterol
. 2018 Jun;
18(1):78.
PMID: 29871592
Background: One-third of patients with non-alcoholic fatty liver disease (NAFLD) develop dysmetabolic iron overload syndrome (DIOS), the pathogenesis of which is unknown. Altered production of the iron-regulatory peptide hepcidin has...
4.
Lorenz F, Pawlowicz E, Klimkowska M, Beshara S, Bulanda Brustad A, Skotnicki A, et al.
Blood Cells Mol Dis
. 2016 Nov;
68:35-42.
PMID: 27816428
Background: The storage of glucosylceramide in macrophages produces an inflammatory response in Gaucher disease type 1 (GD1) resulting in iron metabolism dysregulation and cytokine release. Patients And Methods: The study...
5.
Dahlfors G, Stal P, Hansson E, Barany P, Sisowath C, Onelov L, et al.
Scand J Clin Lab Invest
. 2015 Aug;
75(8):652-8.
PMID: 26264426
Background: Hepcidin-25 is a potential marker for iron disorders with a demand for accessible assays. This study aimed to evaluate a commercial competitive enzyme-linked immunosorbent assay (cELISA) for hepcidin quantitation....
6.
Danielson K, Beshara S, Qureshi A, Heimburger O, Lindholm B, Hansson M, et al.
Clin Kidney J
. 2015 Apr;
7(3):275-81.
PMID: 25852889
Background: Inflammation impairs erythropoiesis, iron availability and is associated with a higher mortality risk in patients with end-stage renal disease. We studied the associations between Delta-He [the difference between the...
7.
Bento C, Percy M, Gardie B, Maia T, van Wijk R, Perrotta S, et al.
Hum Mutat
. 2013 Oct;
35(1):15-26.
PMID: 24115288
Congenital erythrocytosis (CE), or congenital polycythemia, represents a rare and heterogeneous clinical entity. It is caused by deregulated red blood cell production where erythrocyte overproduction results in elevated hemoglobin and...
8.
Hultcrantz M, Admasie J, Beshara S, Landin B, Palmblad J
Lakartidningen
. 2013 Feb;
109(51-52):2354-7.
PMID: 23367550
No abstract available.
9.
Bergman A, Beshara S, Byman I, Karim R, Landin B
Hemoglobin
. 2009 Apr;
33(2):137-42.
PMID: 19373590
A new beta-hemoglobin (Hb) variant, Hb Stockholm [beta7(A4)GluAsp], is described. The variant was characterized by mass spectrometry and DNA sequencing. The new variant is clinically silent but interferes with Hb...
10.
Beshara S, Barany P, Gutierrez A, Wikstrom B
J Nephrol
. 2004 Sep;
17(4):525-30.
PMID: 15372414
Background: The optimal subcutaneous (SC) epoetin alfa strategy is unestablished. The individual variability in dose requirements needs consideration. In this study, prolonged intervals were assessed in relation to varying dose...